{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:53:57Z","timestamp":1767135237612,"version":"build-2238731810"},"publisher-location":"Chichester, UK","reference-count":207,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd001130","type":"reference-entry","created":{"date-parts":[[2003,11,20]],"date-time":"2003-11-20T22:16:04Z","timestamp":1069366564000},"source":"Crossref","is-referenced-by-count":27,"title":["Drugs versus placebo for dysthymia"],"prefix":"10.1002","author":[{"given":"Mauricio","family":"Silva de Lima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Moncrieff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernardo","family":"Soares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,4,20]]},"reference":[{"issue":"6","key":"10.1002\/14651858.CD001130-BIB1|cit1","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/00004714-199312000-00006","article-title":"Ritanserin, Imipramine and placebo in the treatment of dysthymic disorder","volume":"13","author":"Bakish","year":"1993","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD001130-BIB2|cit2","first-page":"53","article-title":"Psychopharmacological treatmente response of patients with a DSM-III diagnosis of dysthymic disorder","volume":"30","author":"Bakish","year":"1994","journal-title":"Psychopharmacology Bulletin"},{"issue":"6","key":"10.1002\/14651858.CD001130-BIB3|cit3","first-page":"355","article-title":"Effect of acetyl-L-carnitine on geriatric patients suffering from dysthymic disorders","volume":"10","author":"Bella","year":"1990","journal-title":"International Journal of Clinical Pharmacological Research"},{"issue":"3","key":"10.1002\/14651858.CD001130-BIB4|cit4","first-page":"155","article-title":"Laevo-acetylcarnitine (Nicetile registered ) treatment of senile depression","volume":"27","author":"Fulgente","year":"1990","journal-title":"Clinical Trials Journal"},{"issue":"4","key":"10.1002\/14651858.CD001130-BIB5|cit5","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1600-0447.1991.tb05533.x","article-title":"5-HT2 receptor antagonism in dysthymic disorder: a double-blind placebo-controlled study with ritanserin","volume":"83","author":"Bersani","year":"1991","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD001130-BIB6|cit6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00004714-199006001-00010","article-title":"Buspirone therapy in anxious elderly patients: a controlled clinical trial","volume":"10","author":"Bohm","year":"1990","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"7","key":"10.1002\/14651858.CD001130-BIB7|cit7","first-page":"309","article-title":"Buspirone therapy for elderly patients with anxiety or depressive neurosis","volume":"51","author":"Bohm","year":"1990","journal-title":"Journal of Clinical Psychiatry"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD001130-BIB10|cit8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0924-9338(96)85188-1","article-title":"Atypical antipsychotic drugs in dysthymia: placebo controlled studies of amisulpride versus imipramine, versus amineptine","volume":"11","author":"Boyer","year":"1996","journal-title":"European Psychiatry: the Journal of the Association of European Psychiatrists"},{"issue":"1 Pt B","key":"10.1002\/14651858.CD001130-BIB8|cit9","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/00002826-199202001-01022","article-title":"Treatment of dysthymia with low-dose amisulpride versus amineptine","volume":"15","author":"Boyer","year":"1992","journal-title":"Clinical Neuropharmacology"},{"issue":"1","key":"10.1002\/14651858.CD001130-BIB9|cit10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000026556","article-title":"Amisulpride versus amineptine and placebo for the treatment of dysthymia","volume":"39","author":"Boyer","year":"1999","journal-title":"Neuropsychobiology"},{"issue":"3","key":"10.1002\/14651858.CD001130-BIB11|cit11","first-page":"242","article-title":"Treatment of dysthymic disorder with low-dose amisulpride. A comparative study of 50 mg\/d amisulpride versus placebo","volume":"5","author":"Costa","year":"1990","journal-title":"Annales De Psychiatrie"},{"issue":"6","key":"10.1002\/14651858.CD001130-BIB12|cit12","first-page":"837","article-title":"Diclofensine (Ro 8-4650), a new psychoactive drug: its efficacy and safety in non-psychotic depression under double-blind placebo-controlled conditions","volume":"28","author":"Paula","year":"1980","journal-title":"Current Therapeutic Research, Clinical & Experimental"},{"issue":"12 Pt 1","key":"10.1002\/14651858.CD001130-BIB13|cit13","first-page":"430","article-title":"Trazodone in the treatment of neurotic depression","volume":"41","author":"Goldberg","year":"1980","journal-title":"Journal of Clinical Psychiatry"},{"issue":"Suppl 6","key":"10.1002\/14651858.CD001130-BIB14|cit14","first-page":"35","article-title":"Treatment of neurotic depression with a new antidepressant","volume":"1","author":"Goldberg","year":"1981","journal-title":"Journal of Clinical Psychiatry"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001130-BIB15|cit15","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000118283","article-title":"Weight changes in antidepressants: a comparison of amitriptyline and tradozodone","volume":"15","author":"Orzack","year":"1986","journal-title":"Neuropsychobiology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001130-BIB16|cit16","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000284523","article-title":"Trazodone: a 5-year review of antidepressant efficacy","volume":"20","author":"Schatzberg","year":"1987","journal-title":"Psychopathology"},{"issue":"3","key":"10.1002\/14651858.CD001130-BIB17|cit17","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0278-5846(96)00007-3","article-title":"Follow-up assessment of medication-treated dysthymia","volume":"20","author":"Hellerstein","year":"1996","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD001130-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1176\/ajp.150.8.1169","article-title":"A randomized double-blind study of fluoxetine versus placebo in the treatment of dysthymia","volume":"150","author":"Hellerstein","year":"1993","journal-title":"American Journal of Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD001130-BIB19|cit19","first-page":"698","article-title":"Imipramine for treatment of chronic depression","volume":"21","author":"Kocsis","year":"1985","journal-title":"Psychopharmacology Bulletim"},{"issue":"3","key":"10.1002\/14651858.CD001130-BIB20|cit20","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1001\/archpsyc.1988.01800270071008","article-title":"Imipramine treatment for chronic depression","volume":"45","author":"Kocsis","year":"1988","journal-title":"Archives of General Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD001130-BIB21|cit21","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1176\/ajp.145.8.997","article-title":"Imipramine and social-vocational adjustment in chronic depression","volume":"145","author":"Kocsis","year":"1988","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD001130-BIB22|cit22","doi-asserted-by":"crossref","first-page":"149b","DOI":"10.1097\/00002826-199202001-00287","article-title":"Treatment of dysthymia with tricyclic antidepressants","volume":"15","author":"Kocsis","year":"1992","journal-title":"Clinical Neuropharmacology"},{"issue":"3","key":"10.1002\/14651858.CD001130-BIB23|cit23","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0165-0327(89)90008-6","article-title":"Prediction of response of chronic depression to imipramine","volume":"17","author":"Kocsis","year":"1989","journal-title":"Journal of Affective Disorders"},{"issue":"1","key":"10.1002\/14651858.CD001130-BIB24|cit24","first-page":"192","article-title":"Chronic depression: demographic and clinical characteristics","volume":"22","author":"Kocsis","year":"1986","journal-title":"Psychopharmacology Bulletin"},{"issue":"1","key":"10.1002\/14651858.CD001130-BIB25|cit25","first-page":"101","article-title":"A preliminary study on the efficacy of sertraline and imipramine on anger attacks in atypical depression and dysthymia","volume":"33","author":"Fava","year":"1997","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD001130-BIB26|cit26","series-title":"151st Annual Meeting of the American Psychiatric Association. Toronto, Ontario, Canada. 30th May 4th June","article-title":"Antidepressant effects on personality in dysthymia","author":"Hellerstein","year":"1998"},{"issue":"9","key":"10.1002\/14651858.CD001130-BIB27|cit27","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1176\/appi.ajp.157.9.1436","article-title":"Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: Effects on personality","volume":"157","author":"Hellerstein","year":"2000","journal-title":"American Journal of Psychiatry"},{"issue":"19","key":"10.1002\/14651858.CD001130-BIB28|cit28","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1001\/jama.280.19.1665","article-title":"Maintenance phase efficacy of sertraline for chronic depression: A randomized controlled trial","volume":"280","author":"Keller","year":"1998","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD001130-BIB29|cit29","series-title":"8th ECNP (European College of Neuropsychopharmacology) Congress, Venice, Italy","article-title":"Acute and long-term pharmacotherapeutic strategies in pure dysthymia: Efficacy of sertraline and imipramine","author":"Kocsis","year":"1995"},{"key":"10.1002\/14651858.CD001130-BIB30|cit30","series-title":"XXth Collegium Internationale Neuro psychopharmacologicum, Melbourne, Australia","article-title":"Sertraline versus imipramine in the acute and continuation treatment of dysthymia","author":"Kocsis","year":"1996"},{"key":"10.1002\/14651858.CD001130-BIB34|cit31","series-title":"Xth World Congress of Psychiatry, Madrid, Spain","article-title":"Sertraline versus imipramine in the acute phase and continuation treatment of dysthymia","author":"Kocsis","year":"1996"},{"key":"10.1002\/14651858.CD001130-BIB31|cit32","series-title":"Sixth World Congress of Biological Psychiatry, Nice, France. June 22 27","article-title":"Maintenance therapy of chronic depression. A placebo-controlled trial of sertraline","author":"Kocsis","year":"1997"},{"key":"10.1002\/14651858.CD001130-BIB32|cit33","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0924-977X(94)90039-6","article-title":"Pharmacotherapy of pure dysthymia: sertraline vs imipramine and placebo","volume":"4","author":"Kocsis","year":"1994","journal-title":"European Neuropsychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD001130-BIB33|cit34","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1176\/ajp.154.3.390","article-title":"Double-blind comparison of sertraline, imipramine and placebo in the treatment of dysthymia: Psychosocial outcomes","volume":"154","author":"Kocsis","year":"1997","journal-title":"American Journal of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD001130-BIB35|cit35","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4088\/JCP.v58n0202","article-title":"The undertreatment of dysthymia","volume":"58","author":"Shelton","year":"1997","journal-title":"Journal of Clinical Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD001130-BIB36|cit36","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1001\/archpsyc.1996.01830090023004","article-title":"A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia","volume":"53","author":"Thase","year":"1996","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD001130-BIB37|cit37","series-title":"XXth Collegium Internationale Neuro psychopharmacologicum, Melbourne, Australia","article-title":"Gender differences in the response to pharmacotherapy among early onset dysthymics","author":"Yonkers","year":"1996"},{"issue":"9","key":"10.1002\/14651858.CD001130-BIB38|cit38","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1001\/archpsyc.1996.01830090013002","article-title":"Maintenance therapy for chronic depression. A controlled clinical trial of desipramine","volume":"53","author":"Kocsis","year":"1996","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD001130-BIB39|cit39","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0165-0327(00)00256-1","article-title":"Maintenance desipramine for dysthymia: a placebo-controlled study","volume":"64","author":"Miller","year":"2001","journal-title":"Journal of Affective Disorders"},{"issue":"1","key":"10.1002\/14651858.CD001130-BIB40|cit40","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/00004714-199402000-00008","article-title":"Duration of antidepressant trials: Clinical and research implications","volume":"14","author":"Donovan","year":"1994","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"8","key":"10.1002\/14651858.CD001130-BIB41|cit41","first-page":"182","article-title":"Treatment of premenstrual dysphoric symptoms in depressed women","volume":"46","author":"Glick","year":"1991","journal-title":"Journal of the American Medical Womens Association"},{"issue":"3","key":"10.1002\/14651858.CD001130-BIB42|cit42","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/00004714-198606000-00004","article-title":"Effects of antidepressant medication on sexual function: A controlled study","volume":"6","author":"Harrison","year":"1986","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD001130-BIB43|cit43","first-page":"85","article-title":"A controlled study of the effects of antidepressants on sexual function","volume":"21","author":"Harrison","year":"1985","journal-title":"Psychopharmacology Bulletin"},{"issue":"7","key":"10.1002\/14651858.CD001130-BIB44|cit44","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1001\/archpsyc.1984.01790180039005","article-title":"Phenelzine versus imipramine in atypical depression","volume":"41","author":"Liebowitz","year":"1984","journal-title":"Archives of General Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD001130-BIB45|cit45","first-page":"22","article-title":"Psychopharmacologic validation of atypical depression","volume":"45","author":"Liebowitz","year":"1984","journal-title":"Journal of Clinical Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD001130-BIB46|cit46","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1001\/archpsyc.1988.01800260037004","article-title":"Antidepressant specificity in atypical depression","volume":"45","author":"Liebowitz","year":"1988","journal-title":"Archives of General Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD001130-BIB47|cit47","first-page":"107","article-title":"Attrition and its consequences in a clinical trial of placebo, imipramine, and phenelzine","volume":"21","author":"Markowitz","year":"1985","journal-title":"Psychopharmacology Bulletin"},{"issue":"1","key":"10.1002\/14651858.CD001130-BIB48|cit48","first-page":"169","article-title":"Treatment of tricyclic refractory depression with a monoamine oxidase inhibitor antidepressant","volume":"23","author":"McGrath","year":"1987","journal-title":"Psychopharmacology Bulletin"},{"issue":"3","key":"10.1002\/14651858.CD001130-BIB49|cit49","first-page":"197","article-title":"Predictive value of symptoms of atypical depression for differential drug treatment outcome","volume":"12","author":"McGrath","year":"1992","journal-title":"Journal of Clinincal Psychopharmacology"},{"issue":"8","key":"10.1002\/14651858.CD001130-BIB50|cit50","first-page":"336","article-title":"Treatment response of depressed outpatients unresponsive to both a tricyclic and a monoamine oxidase inhibitor antidepressant","volume":"55","author":"McGrath","year":"1994","journal-title":"Journal of Clinical Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD001130-BIB51|cit51","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1176\/ajp.150.1.118","article-title":"A double-blind crossover trial of imipramine and phenelzine for outpatients with treatment-refractory depression","volume":"150","author":"McGrath","year":"1993","journal-title":"American Journal of Psychiatry"},{"issue":"10","key":"10.1002\/14651858.CD001130-BIB52|cit52","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1176\/ajp.145.10.1322b","article-title":"Phenelzine versus imipramine for atypical depression","volume":"145","author":"Nakdimen","year":"1988","journal-title":"American Journal of Psychiatry"},{"issue":"Spec No 3","key":"10.1002\/14651858.CD001130-BIB63|cit53","first-page":"491","article-title":"Impact of personality factors in depression","volume":"19","author":"Quitkin","year":"1993","journal-title":"Encephale"},{"issue":"4","key":"10.1002\/14651858.CD001130-BIB53|cit54","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1001\/archpsyc.1991.01810280035005","article-title":"Response to phenelzine and imipramine in placebo nonresponders with atypical depression. A new aplication of the crossover design","volume":"48","author":"Quitkin","year":"1991","journal-title":"Archives of General Psychiatry"},{"issue":"10","key":"10.1002\/14651858.CD001130-BIB54|cit55","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1001\/archpsyc.1990.01810220051006","article-title":"Atypical depression, panic attacks, and response to imipramine and phenelzine. A replication","volume":"47","author":"Quitkin","year":"1990","journal-title":"Archives of General Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD001130-BIB55|cit56","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1001\/archpsyc.1989.01810090029005","article-title":"Phenelzine and imipramine in mood reactive depressives. Further delineation of the syndrome of atypical depression","volume":"46","author":"Quitkin","year":"1989","journal-title":"Archives of General Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD001130-BIB56|cit57","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1001\/archpsyc.1987.01800150071009","article-title":"Use of pattern analysis to identify true drug response. A replication","volume":"44","author":"Quitkin","year":"1987","journal-title":"Archives of General Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD001130-BIB57|cit58","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0022-3956(86)90004-X","article-title":"Study duration in antidepressant research: advantages of a 12-week trial","volume":"20","author":"Quitkin","year":"1986","journal-title":"Journal of Psychiatric Research"},{"issue":"3","key":"10.1002\/14651858.CD001130-BIB58|cit59","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1176\/ajp.145.3.306","article-title":"Phenelzine versus imipramine in the treatment of probable atypical depression: defining syndrome boundaries of selective MAOI responders","volume":"145","author":"Quitkin","year":"1988","journal-title":"American Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD001130-BIB60|cit60","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1176\/ajp.150.4.566","article-title":"Further evidence that a placebo response to antidepressants can be identified","volume":"150","author":"Quitkin","year":"1993","journal-title":"American Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD001130-BIB59|cit61","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1176\/ajp.150.4.562","article-title":"Loss of drug effects during continuation therapy","volume":"150","author":"Quitkin","year":"1993","journal-title":"American Journal of Psychiatry"},{"issue":"10","key":"10.1002\/14651858.CD001130-BIB61|cit62","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1001\/archpsyc.1997.01830220100016","article-title":"The identification and validation of distinct depressive syndromes in a population-based sample of female twins","volume":"54","author":"Quitkin","year":"1997","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD001130-BIB62|cit63","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1192\/S0007125000292465","article-title":"Columbia atypical depression. A subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placebo. British Journal of Psychiatry 1993; 163(suppl","volume":"21","author":"Quitkin","year":"1993","journal-title":"British Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD001130-BIB64|cit64","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0165-1781(86)90094-6","article-title":"How blind is blind? Assessment of patient and doctor medication guesses in a placebo-controlled trial of imipramine and phenelzine","volume":"19","author":"Rabkin","year":"1986","journal-title":"Psychiatry Research"},{"issue":"1","key":"10.1002\/14651858.CD001130-BIB65|cit65","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0165-1781(87)90057-6","article-title":"Baseline characteristics of 10-day placebo washout responders in antidepressant trials","volume":"21","author":"Rabkin","year":"1987","journal-title":"Psychiatry Research"},{"issue":"1","key":"10.1002\/14651858.CD001130-BIB66|cit66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/1098-108X(199401)15:1<1::AID-EAT2260150102>3.0.CO;2-E","article-title":"A double-blind placebo-controlled comparison of phenelzine and imipramine in the treatment of bulimia in atypical depressives","volume":"15","author":"Rothschild","year":"1994","journal-title":"International Journal of Eating Disorders"},{"issue":"2","key":"10.1002\/14651858.CD001130-BIB67|cit67","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0165-1781(88)90051-0","article-title":"Tyramine sulfate excretion may be a better predictor of antidepressant response than monoamine oxidase activity","volume":"25","author":"Stewart","year":"1988","journal-title":"Psychiatry Research"},{"issue":"5","key":"10.1002\/14651858.CD001130-BIB70|cit68","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1176\/ajp.149.5.615","article-title":"Can mildly depressed outpatients with atypical depression benefit from antidepressants?","volume":"149","author":"Stewart","year":"1992","journal-title":"American Journal of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD001130-BIB71|cit69","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0893-133X(01)00313-X","article-title":"Do age of onset and course of illness predict different treatment outcome among DSM IV depressive disorders with atypical features?","volume":"26","author":"Stewart","year":"2002","journal-title":"Neuropsychopharmacology"},{"issue":"12","key":"10.1002\/14651858.CD001130-BIB68|cit70","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1001\/archpsyc.1989.01810120022005","article-title":"Relevance of DSM-III depressive subtype and chronicity of antidepressant efficacy in atypical depression","volume":"46","author":"Stewart","year":"1989","journal-title":"Archives of General Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD001130-BIB69|cit71","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00004714-199312000-00004","article-title":"Chronic depression: response to placebo, imipramine, and phenelzine","volume":"13","author":"Stewart","year":"1993","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD001130-BIB72|cit72","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0193-953X(18)30161-8","article-title":"Atypical depression. A valid clinical entity?","volume":"16","author":"Stewart","year":"1993","journal-title":"Psychiatric Clinics of North America"},{"key":"10.1002\/14651858.CD001130-BIB74|cit73","series-title":"150th Annual Meeting of the American Psychiatric Association. San Diego, California, USA. 17 22 May","article-title":"Atypical depression: Is it a valid clinical entity?","author":"Stewart","year":"1997"},{"issue":"2","key":"10.1002\/14651858.CD001130-BIB73|cit74","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0165-1781(88)90053-4","article-title":"Social functioning in chronic depression: effect of 6 weeks of antidepressant treatment","volume":"25","author":"Stewart","year":"1988","journal-title":"Psychiatry Research"},{"key":"10.1002\/14651858.CD001130-BIB75|cit75","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/hup.470030308","article-title":"Cilobamine in the treatment of atypical depression","volume":"3","author":"Wager","year":"1988","journal-title":"Human Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD001130-BIB76|cit76","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000468555","article-title":"A collaborative study of a new antidepressant, viloxazine, in neurotic and endogenous depressives","volume":"17","author":"Guy","year":"1982","journal-title":"International Pharmacopsychiatry"},{"key":"10.1002\/14651858.CD001130-BIB77|cit77","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1192\/bjp.137.5.440","article-title":"Viloxazine in the treatment of depressive neurosis: A controlled clinical study with doxepin and placebo","volume":"137","author":"McEvoy","year":"1980","journal-title":"British Journal of Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD001130-BIB78|cit78","first-page":"103","article-title":"Multicentre, controlled, randomized, double-blind vs placebo study of minaprine in elderly patients suffering from prolonged depressive reaction","volume":"39","author":"Parnetti","year":"1991","journal-title":"Giornale di Gerontologia"},{"issue":"4","key":"10.1002\/14651858.CD001130-BIB79|cit79","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF03259242","article-title":"Multicentre controlled randomised double-blind placebo study of minaprine in elderly patients suffering from prolonged depressive reaction","volume":"6","author":"Parnetti","year":"1993","journal-title":"Drug Investigation"},{"issue":"1","key":"10.1002\/14651858.CD001130-BIB80|cit80","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000468555","article-title":"A collaborative study of a new antidepressant, viloxazine, in neurotic and endogenous depressives","volume":"17","author":"Guy","year":"1982","journal-title":"International Pharmacopsychiatry"},{"issue":"3","key":"10.1002\/14651858.CD001130-BIB81|cit81","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000468437","article-title":"Viloxazine in the treatment of depressive neurosis: A placebo and standard (imipramine) controlled clinical study","volume":"15","author":"Petrie","year":"1980","journal-title":"International Pharmacopsychiatry"},{"key":"10.1002\/14651858.CD001130-BIB82|cit82","series-title":"XXIst Collegium Internationale Neuro psychopharmacologicum, Glasgow, Scotland. 12th 16th July","article-title":"Cytokines in dysthymia","author":"Ravindran","year":"1998"},{"issue":"11","key":"10.1002\/14651858.CD001130-BIB83|cit83","doi-asserted-by":"crossref","first-page":"821","DOI":"10.4088\/JCP.v61n1103","article-title":"Treatment of dysthymia with sertraline: a double-blind, placebo-controlled trial in dysthymic patients without major depression","volume":"61","author":"Ravindran","year":"2000","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD001130-BIB84|cit84","series-title":"150th Annual Meeting of the American Psychiatric Association, San Diego California, USA, 17-22 May","article-title":"A double-blind, placebo-controlled study of sertraline in the treatment of outpatients with dysthymia","author":"Ravindran","year":"1997"},{"key":"10.1002\/14651858.CD001130-BIB85|cit85","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/ddr.430080124","article-title":"Thymosthenic effects of ritanserin (R 55667), a centrally acting serotonin-S2 receptor blocker","volume":"8","author":"Reyntjens","year":"1986","journal-title":"Drug Development Research"},{"issue":"4","key":"10.1002\/14651858.CD001130-BIB86|cit86","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0033-3182(68)71844-2","article-title":"Iprindole in neurotic depressed general practice patients: A controlled study","volume":"9","author":"Rickels","year":"1968","journal-title":"Psychosomatics"},{"issue":"10","key":"10.1002\/14651858.CD001130-BIB87|cit87","first-page":"514","article-title":"A controlled evaluation of U-23,807A in the neurotic depressive syndrome","volume":"9","author":"Shipley","year":"1967","journal-title":"Current Therapeutic Research, Clinical & Experimental"},{"issue":"22","key":"10.1002\/14651858.CD001130-BIB88|cit88","first-page":"305","article-title":"Therapy of mild or moderate depression with Hypericum","volume":"135","author":"Harrer","year":"1993","journal-title":"Munchener Medizinische Wochenschrift"},{"issue":"1","key":"10.1002\/14651858.CD001130-BIB89|cit89","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0944-7113(11)80016-4","article-title":"Treatment of mild\/moderate depressions with Hypericum","volume":"1","author":"Harrer","year":"1994","journal-title":"Phytomedicine"},{"issue":"7A","key":"10.1002\/14651858.CD001130-BIB92|cit90","first-page":"7","article-title":"Improvement in psychovegetative symptoms by hypericum in a multicentre double-blind study","volume":"10","author":"Sommer","year":"1991","journal-title":"Nervenheilkunde"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001130-BIB91|cit91","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/089198879400700104","article-title":"Placebo-controlled double-blind study examining the effectiveness of an hypericum preparation in 105 mildly depressed patients","volume":"7","author":"Sommer","year":"1994","journal-title":"Journal of Geriatric Psychiatry and Neurology"},{"issue":"6A","key":"10.1002\/14651858.CD001130-BIB90|cit92","first-page":"274","article-title":"Placebo controlled double blind study examining the effectiveness of an hypericum preparation in 105 patients with depressions","volume":"12","author":"Sommer","year":"1993","journal-title":"Nervenheilkunde"},{"issue":"6","key":"10.1002\/14651858.CD001130-BIB93|cit93","first-page":"355","article-title":"Controlled comparison of RO 11-1163 (moclobemide) and placebo in the treatment of depression","volume":"92","author":"Botte","year":"1992","journal-title":"Acta Psychiatrica Belgica"},{"key":"10.1002\/14651858.CD001130-BIB94|cit94","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1600-0447.1990.tb05323.x","article-title":"Moclobemide versus placebo in the treatment of depression: a multicentre study in Belgium","volume":"360","author":"Botte","year":"1990","journal-title":"Acta Psychiatrica Scandinavica. Supplementum"},{"key":"10.1002\/14651858.CD001130-BIB95|cit95","first-page":"77","article-title":"Review of comparative clinical trials. Moclobemide vs tricyclic antidepressants and vs placebo in depressive states","volume":"28","author":"Stabl","year":"1989","journal-title":"Journal of Neural Transmission. Supplementum"},{"issue":"4","key":"10.1002\/14651858.CD001130-BIB96|cit96","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1600-0447.1977.tb00228.x","article-title":"Pizotifen as an antidepressant","volume":"56","author":"Standal","year":"1977","journal-title":"Acta Psychiatric Scandinavia"},{"issue":"2","key":"10.1002\/14651858.CD001130-BIB97|cit97","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1176\/ajp.148.2.193","article-title":"Heterogeneity of clinical response during placebo treatment","volume":"148","author":"Quitkin","year":"1991","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD001130-BIB98|cit98","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0165-1781(87)90057-6","article-title":"Baseline characteristics of 10-day placebo washout responders in antidepressant trials","volume":"21","author":"Rabkin","year":"1987","journal-title":"Psychiatry Research"},{"issue":"12","key":"10.1002\/14651858.CD001130-BIB99|cit99","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1001\/archpsyc.1985.01790350022005","article-title":"Treatment outcome validation of DSM-III depressive subtypes. Clinical usefulness in outpatients with mild to moderate depression","volume":"42","author":"Stewart","year":"1985","journal-title":"Archives of General Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD001130-BIB100|cit100","first-page":"136","article-title":"Efficacy of desipramine in mildly depressed patients: A double-blind, placebo-controlled trial","volume":"17","author":"Stewart","year":"1981","journal-title":"Psychopharmacology Bulletin"},{"issue":"2","key":"10.1002\/14651858.CD001130-BIB101|cit101","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1001\/archpsyc.1983.01790020100010","article-title":"Efficacy of desipramine in depressed outpatients","volume":"40","author":"Stewart","year":"1983","journal-title":"Archives of General Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD001130-BIB102|cit102","first-page":"546","article-title":"Comparative evaluation of the antidepressive properties of opipramol, imipramine and placebo in neurotic depression","volume":"95","author":"Tetreault","year":"1966","journal-title":"L'Union Medique du Canada"},{"issue":"4","key":"10.1002\/14651858.CD001130-BIB104|cit103","first-page":"138","article-title":"Maprotiline versus imipramine and placebo in neurotic depression","volume":"42","author":"Velde","year":"1981","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD001130-BIB103|cit104","first-page":"138","article-title":"Maprotiline versus imipramine and placebo in neurotic depression","volume":"42","author":"Velde","year":"1981","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD001130-BIB105|cit105","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1192\/bjp.170.4.345","article-title":"Controlled efficacy study of fluoxetine in dysthymia","volume":"170","author":"Vanelle","year":"1997","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD001130-BIB106|cit106","series-title":"Sixth World Congress of Biological Psychiatry, Nice, France. June 22 27","article-title":"Six-month controlled efficacity study of fluoxetine in the treatment of dysthymia","author":"Vanelle","year":"1997"},{"issue":"4","key":"10.1002\/14651858.CD001130-BIB107|cit107","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00004850-199707000-00001","article-title":"Moclobemide and imipramine in chronic depression (dysthymia): an international double-blind, placebo-controlled trial","volume":"12","author":"Versiani","year":"1997","journal-title":"International Clinical Psychopharmacology"},{"issue":"12","key":"10.1002\/14651858.CD001130-BIB108|cit108","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1001\/jama.284.12.1519","article-title":"Treatment of dysthymia and minor depression in primary care: A randomized controlled trial in older adults","volume":"284","author":"Williams","year":"2000","journal-title":"JAMA"},{"issue":"741","key":"10.1002\/14651858.CD001130-BIB109|cit109","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/bmj.1.5741.133","article-title":"Controlled trial of amitriptyline in general practice","volume":"1","author":"Blashki","year":"1971","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD001130-BIB110|cit110","series-title":"V World Congress of Psychiatry, Ciudad de Mexico","article-title":"A controlled trial ot an antidepressant (amitriptyline) in general-practice","author":"Blashki","year":"1971"},{"issue":"5","key":"10.1002\/14651858.CD001130-BIB111|cit111","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1177\/070674378002500507","article-title":"A placebo controlled evaluation of L-tryptophan in depression in the elderly","volume":"25","author":"Cooper","year":"1980","journal-title":"Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie"},{"issue":"4 Pt 2","key":"10.1002\/14651858.CD001130-BIB112|cit112","first-page":"43","article-title":"Double-blind comparison of the efficacy and safety of nomifensine maleate vs placebo in depressed outpatients","volume":"45","author":"Georgia","year":"1984","journal-title":"Journal of Clinical Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD001130-BIB113|cit113","first-page":"825","article-title":"Oxazepam-protriptyline: A double-blind phase II evaluation of the efficacy and safety of the combination versus placebo in neurotic, depressed and anxious psychiatric outpatients","volume":"18","author":"Gilbert","year":"1975","journal-title":"Current Therapeutic Research, Clinical & Experimental"},{"issue":"7","key":"10.1002\/14651858.CD001130-BIB114|cit114","first-page":"346","article-title":"Phenelzine for chronic depression: a study of continuation treatment","volume":"47","author":"Harrison","year":"1986","journal-title":"Journal of Clinical Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD001130-BIB115|cit115","first-page":"219","article-title":"Ipsapirone: evidence for efficacy in depression","volume":"26","author":"Heller","year":"1990","journal-title":"Psychopharmacology Bulletim"},{"key":"10.1002\/14651858.CD001130-BIB116|cit116","first-page":"171","article-title":"Promising anxiolytics? A new class of drugs: the azapirones","volume-title":"Serotonin 1A receptors in depression and anxiety","author":"Keppel Hesselink","year":"1992"},{"key":"10.1002\/14651858.CD001130-BIB117|cit117","first-page":"163","article-title":"Efficacy of azapirones in depression","volume-title":"Serotonin 1A receptors in depression and anxiety","author":"Kurtz","year":"1992"},{"issue":"314","key":"10.1002\/14651858.CD001130-BIB118|cit118","first-page":"393","article-title":"Double-blind placebo-controlled trial of amitriptyline among depressed patients in general practice","volume":"38","author":"Hollyman","year":"1988","journal-title":"Journal of the Royal College of General Practitioners"},{"issue":"1","key":"10.1002\/14651858.CD001130-BIB119|cit119","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1055\/s-2007-1014639","article-title":"Are tricyclic antidepressants useful for mild depression? A placebo controlled trial","volume":"21","author":"Paykel","year":"1988","journal-title":"Pharmacopsychiatry"},{"issue":"1","key":"10.1002\/14651858.CD001130-BIB120|cit120","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0165-0327(88)90075-4","article-title":"Predictors of therapeutic benefit from amitriptyline in mild depression: a general practice placebo-controlled trial","volume":"14","author":"Paykel","year":"1988","journal-title":"Journal of Affective Disorders"},{"issue":"707","key":"10.1002\/14651858.CD001130-BIB121|cit121","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1136\/bmj.2.5707.482-a","article-title":"Drugs in depressive illness","volume":"2","author":"Hussain","year":"1970","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD001130-BIB122|cit122","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1192\/bjp.146.5.515","article-title":"An evaluation of alprazolam in the treament of reactive or neurotic (secondary) depression","volume":"146","author":"Imlah","year":"1985","journal-title":"British Journal of Psychiatry"},{"issue":"5 Pt 2","key":"10.1002\/14651858.CD001130-BIB123|cit123","first-page":"134","article-title":"Safety and efficacy of bupropion in elderly patients: preliminary observations","volume":"44","author":"Kane","year":"1983","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD001130-BIB124|cit124","series-title":"Conference not specified","article-title":"Sertraline maintenance treatment of recurrent chronic depression","author":"Keller","year":"1996"},{"key":"10.1002\/14651858.CD001130-BIB125|cit125","series-title":"150th Annual Meeting of the American Psychiatric Association. San Diego, California, USA. 17 22 May","article-title":"Sertraline maintenence treatment of recurrent chronic depression","author":"Keller","year":"1997"},{"issue":"8","key":"10.1002\/14651858.CD001130-BIB126|cit126","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1001\/archpsyc.59.8.723","article-title":"Psychosocial outcomes following long-term, double-blind treatment of chronic depression with sertraline vs placebo","volume":"59","author":"Kocsis","year":"2002","journal-title":"Archives of General Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD001130-BIB127|cit127","first-page":"56","article-title":"Long-term follow-up of chronic depression treated with imipramine","volume":"52","author":"Kocsis","year":"1991","journal-title":"Journal of Clinical Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD001130-BIB128|cit128","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF02246151","article-title":"Treatment of depressive outpatients with lorazepam, alprazolam, amytriptyline and placebo","volume":"120","author":"Laakman","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD001130-BIB129|cit129","first-page":"828","article-title":"Treatment of minor depressive states in general medicine: clinical trial with a hydrazine derivative","volume":"Suppl 6","author":"Linquette","year":"1968","journal-title":"Lille Medical"},{"issue":"1","key":"10.1002\/14651858.CD001130-BIB130|cit130","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/archpsyc.1986.01800010070009","article-title":"Imipramine and chlordiazepoxide in depressive and anxiety disorders. I. Efficacy in depressed outpatients","volume":"43","author":"Lipman","year":"1986","journal-title":"Archives of General Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD001130-BIB131|cit131","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/BF02245573","article-title":"Treatment of chronic depression with sulpiride: evidence of efficacy in placebo-controlled single case studies","volume":"115","author":"Maier","year":"1994","journal-title":"Psychopharmacology"},{"issue":"12","key":"10.1002\/14651858.CD001130-BIB132|cit132","first-page":"525","article-title":"Methylphenidate in mild depression: A double-blind controlled trial","volume":"46","author":"Mattes","year":"1985","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD001130-BIB133|cit133","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000118218","article-title":"Placebo-controlled study of mianserin in depressed outpatients","volume":"14","author":"McGrath","year":"1985","journal-title":"Neuropsychobiology"},{"issue":"2","key":"10.1002\/14651858.CD001130-BIB134|cit134","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1176\/ajp.148.2.193","article-title":"Heterogeneity of clinical response during placebo treatment","volume":"148","author":"Quitkin","year":"1991","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD001130-BIB135|cit135","first-page":"9","article-title":"Heterogeneity of clinical response during placebo treatment","volume":"21","author":"Rabkin","year":"1987","journal-title":"Baseline characteristics of 10-day placebo washout responders in antidepressant trials"},{"issue":"1","key":"10.1002\/14651858.CD001130-BIB136|cit136","first-page":"63","article-title":"A placebo-controlled trial of l-deprenyl in atypical depression","volume":"25","author":"McGrath","year":"1989","journal-title":"Psychopharmacology Bulletim"},{"issue":"5","key":"10.1002\/14651858.CD001130-BIB137|cit137","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00004714-199410000-00011","article-title":"Gepirone treatment of atypical depression: preliminary evidence of serotonergic involvement","volume":"14","author":"McGrath","year":"1994","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"5","key":"10.1002\/14651858.CD001130-BIB138|cit138","first-page":"330","article-title":"An evaluation of pyrisuccideanol maleate (nadex) in the treatment of mild to moderate depression in patients aged 55 years and over, presenting in general practice","volume":"9","author":"Murphy","year":"1981","journal-title":"Journal of Internal Medicine Research"},{"issue":"3","key":"10.1002\/14651858.CD001130-BIB139|cit139","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/BF00216069","article-title":"Effects of ritanserin on sleep disturbances of dysthymic patients","volume":"96","author":"Paiva","year":"1988","journal-title":"Psychopharmacology"},{"issue":"699","key":"10.1002\/14651858.CD001130-BIB140|cit140","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1136\/bmj.1.5699.773","article-title":"Depressive illness in a general practice. A demographic study and a controlled trial of imipramine","volume":"1","author":"Porter","year":"1970","journal-title":"British Medical Journal"},{"issue":"2","key":"10.1002\/14651858.CD001130-BIB145|cit141","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/00005053-197408000-00006","article-title":"Age-sex differences in response to antidepressant drugs","volume":"159","author":"Raskin","year":"1974","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD001130-BIB141|cit142","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1017\/S0033291700006644","article-title":"Initial response to drugs in depressive illness and psychiatric and community adjustment a year later","volume":"8","author":"Raskin","year":"1978","journal-title":"Psychological Medicine"},{"issue":"2","key":"10.1002\/14651858.CD001130-BIB142|cit143","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/00005053-197302000-00005","article-title":"A model for drug use with depressed patients","volume":"156","author":"Raskin","year":"1973","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1002\/14651858.CD001130-BIB143|cit144","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1017\/S0033291700007509","article-title":"The endogenous-neurotic distinction as a predictor of response to antidepressant drugs","volume":"6","author":"Raskin","year":"1976","journal-title":"Psychological Medicine"},{"issue":"2","key":"10.1002\/14651858.CD001130-BIB144|cit145","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1001\/archpsyc.1970.01750020068009","article-title":"Differential response to chlorpromazine, imipramine and placebo. A stuty of subgroups of hospitalized depressed patients","volume":"23","author":"Raskin","year":"1970","journal-title":"Archives of General Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD001130-BIB146|cit146","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF00429128","article-title":"True and apparent side effects in a controlled trial of chlorpromazine and imipramine in depression","volume":"38","author":"Schulterbrandt","year":"1974","journal-title":"Psychopharmacologia"},{"issue":"1","key":"10.1002\/14651858.CD001130-BIB149|cit147","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/j.1552-4604.1972.tb00031.x","article-title":"Adverse reactions to phenelzine: results of a nine-hospital depression study","volume":"12","author":"Raskin","year":"1972","journal-title":"Journal of Clinical Pharmacology & New Drugs"},{"issue":"2","key":"10.1002\/14651858.CD001130-BIB150|cit148","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/00005053-197408000-00006","article-title":"Age-sex differences in response to antidepressant drugs","volume":"159","author":"Raskin","year":"1974","journal-title":"Journal of Nervous and Mental Disease"},{"issue":"2","key":"10.1002\/14651858.CD001130-BIB147|cit149","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/00005053-197302000-00005","article-title":"A model for drug use with depressed patients","volume":"156","author":"Raskin","year":"1973","journal-title":"Journal of Nervous and Mental Disease"},{"issue":"1","key":"10.1002\/14651858.CD001130-BIB148|cit150","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/archpsyc.1974.01760070050008","article-title":"Depression subtypes and response to phenelzine, diazepam, and a placebo. Results of a nine hospital collaborative study","volume":"30","author":"Raskin","year":"1974","journal-title":"Archives of General Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD001130-BIB151|cit151","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1176\/ajp.127.2.208","article-title":"Amitriptiline and trimipramine in neurotic depressed outpatients: a collaborative study","volume":"127","author":"Rickels","year":"1970","journal-title":"American Journal of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD001130-BIB152|cit152","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0033-3182(71)71499-6","article-title":"The combination of protriptyline and oxazepam in depressed neurotic general practice patients","volume":"12","author":"Rickels","year":"1971","journal-title":"Psychosomatics"},{"issue":"7","key":"10.1002\/14651858.CD001130-BIB153|cit153","first-page":"457","article-title":"Combination of meprobamate and benactyzine (Deprol) and constituents in neurotic depressed outpatients","volume":"32","author":"Rickels","year":"1971","journal-title":"Diseases of the Nervous System"},{"issue":"2","key":"10.1002\/14651858.CD001130-BIB154|cit154","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/j.1552-4604.1974.tb02302.x","article-title":"Pipradrol in mild depression: A controlled study","volume":"14","author":"Rickels","year":"1974","journal-title":"Journal of Clinical Pharmacology"},{"issue":"2","key":"10.1002\/14651858.CD001130-BIB155|cit155","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0165-0327(84)90026-0","article-title":"Responses to phenelzine and amitriptyline absence of differential predictors by multiple regression analysis","volume":"6","author":"Bhat","year":"1984","journal-title":"Journal of Affective Disorders"},{"issue":"9","key":"10.1002\/14651858.CD001130-BIB156|cit156","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1001\/archpsyc.1982.04290090035008","article-title":"Response to phenelzine and amitriptyline in subtypes of outpatient depression","volume":"39","author":"Paykel","year":"1982","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD001130-BIB157|cit157","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1192\/bjp.141.3.243","article-title":"Influence of acetylator phenotype on antidepressant effects of phenelzine","volume":"141","author":"Paykel","year":"1982","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD001130-BIB158|cit158","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1192\/bjp.140.5.475","article-title":"Phenelzine and amitriptyline: effects on symptoms of neurotic depression","volume":"140","author":"Rowan","year":"1982","journal-title":"British Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD001130-BIB159|cit159","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1600-0447.1985.tb02575.x","article-title":"Separate and combined anxiolytic and anti-depressant treatment of mixed anxiety\/depression. A double-blind, placebo controlled comparison","volume":"72","year":"1985","journal-title":"Acta Psychiatric Scandinavia"},{"issue":"3","key":"10.1002\/14651858.CD001130-BIB160|cit160","first-page":"201","article-title":"Controlled comparison of bromazepam, amitriptyline, and placebo in anxiety-depressive neurosis","volume":"38","author":"Shammas","year":"1977","journal-title":"Diseases of Nervous System"},{"issue":"1","key":"10.1002\/14651858.CD001130-BIB161|cit161","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1176\/ajp.154.1.31","article-title":"Prophylactic efficacy of phenelzine and imipramine in chronic atypical depression: likelihood of recurrence on discontinuation after 6 months' remission","volume":"154","author":"Stewart","year":"1997","journal-title":"American Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD001130-BIB162|cit162","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1017\/S0033291700049047","article-title":"The treatment of depression in general practice: a comparison of l-tryptophan, amitriptyline, and a combination of l-tryptophan and amitriptyline with placebo","volume":"12","author":"Thomson","year":"1982","journal-title":"Psychological Medicine"},{"issue":"721","key":"10.1002\/14651858.CD001130-BIB163|cit163","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0140-6736(71)90153-X","article-title":"Amantadine in depression","volume":"2","author":"Vale","year":"1971","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001130-BIB164|cit164","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/hup.470030308","article-title":"Cilobamine in the treatment of atypical depression","volume":"3","author":"Wager","year":"1988","journal-title":"Human Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD001130-BIB165|cit165","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/070674378803300204","article-title":"Dysthymia: a randomized study of cognitive marital therapy and antidepressants","volume":"33","author":"Waring","year":"1988","journal-title":"Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie"},{"key":"10.1002\/14651858.CD001130-BIB166|cit166","series-title":"15th Congress, Collegium Internationale Neuro-Psychopharmacologicum","first-page":"168","article-title":"Ritanserin, an original thymostenic for the treatment of dysthymia. A double-blind placebo-controlled study","author":"Arriaga","year":"1986"},{"issue":"4","key":"10.1002\/14651858.CD001130-BIB167|cit167","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1055\/s-2007-1017421","article-title":"A placebo-controlled study of the antidepressant activity of moclobemide, a new MAO-A inhibitor","volume":"17","author":"Casacchia","year":"1984","journal-title":"Pharmacopsychiatry"},{"issue":"2","key":"10.1002\/14651858.CD001130-BIB168|cit168","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0165-0327(83)90012-5","article-title":"Isocarboxazid. Efficacy and tolerance","volume":"5","author":"Davidson","year":"1983","journal-title":"Journal of Affective Disorders"},{"issue":"3","key":"10.1002\/14651858.CD001130-BIB169|cit169","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00004714-198606000-00003","article-title":"The effects of isocarboxazid on blood pressure and pulse","volume":"6","author":"Davidson","year":"1986","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD001130-BIB170|cit170","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1001\/archpsyc.1988.01800260024003","article-title":"An efficacy study of isocarboxazid and placebo in depression, and its relationship to depressive nosology","volume":"45","author":"Davidson","year":"1988","journal-title":"Archives of General Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD001130-BIB171|cit171","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00004714-198506000-00002","article-title":"Monoamine oxidase inhibitors in the treatment of atypical depression","volume":"5","author":"Zisook","year":"1985","journal-title":"Journal of-Clinical Psychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD001130-BIB172|cit172","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/gps.930020409","article-title":"Sulpiride and placebo in depressed elderly outpatients: A double-blind study","volume":"2","author":"Kivela","year":"1987","journal-title":"International Journal of Geriatric Psychiatry"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD001130-BIB173|cit173","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0924-9338(96)85188-1","article-title":"Atypical antipsychotic drugs in dysthymia: placebo controlled studies of amisulpride versus imipramine, versus amineptine","volume":"11","author":"Boyer","year":"1996","journal-title":"European Psychiatry: the Journal of the Association of European Psychiatrists"},{"issue":"3","key":"10.1002\/14651858.CD001130-BIB176|cit174","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0924-9338(96)85187-X","article-title":"Pharmacological interventions in dysthymia","volume":"11","author":"Lecrubier","year":"1996","journal-title":"European Psychiatry"},{"issue":"1 Pt B","key":"10.1002\/14651858.CD001130-BIB174|cit175","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/00002826-199202001-01025","article-title":"Amisulpride versus imipramine and placebo in dysthymia","volume":"15","author":"Lecrubier","year":"1992","journal-title":"Clinical Neuropharmacology"},{"issue":"2","key":"10.1002\/14651858.CD001130-BIB175|cit176","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0165-0327(96)00103-6","article-title":"Amisulpride versus imipramine and placebo in dysthymia and major depression","volume":"43","author":"Lecrubier","year":"1997","journal-title":"Journal of Affective Disorders"},{"key":"10.1002\/14651858.CD001130-BIB177|cit177","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1192\/bjp.169.1.93","article-title":"The Nottingham Study of Neurotic Disorder: influence of cognitive therapists on outcome","volume":"169","author":"Kingdon","year":"1996","journal-title":"British Journal of Psychiatry"},{"issue":"8618","key":"10.1002\/14651858.CD001130-BIB178|cit178","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0140-6736(88)90760-X","article-title":"Nottingham study of neurotic disorder","volume":"2","author":"Klein","year":"1988","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD001130-BIB179|cit179","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1017\/S0033291798007119","article-title":"Prediction of outcome in neurotic disorder: a 5-year prospective study","volume":"28","author":"Seivewright","year":"1998","journal-title":"Psychological Medicine"},{"issue":"3","key":"10.1002\/14651858.CD001130-BIB180|cit180","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/(SICI)1520-6394(2000)11:3<105::AID-DA4>3.0.CO;2-H","article-title":"Longitudinal study of the influence of life events and personality status on diagnostic change in three neurotic disorders","volume":"11","author":"Seivewright","year":"2000","journal-title":"Depression & Anxiety"},{"issue":"2","key":"10.1002\/14651858.CD001130-BIB181|cit181","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1017\/S0033291700017736","article-title":"The Nottingham Study of Neurotic Disorder: relationship between personality status and symptoms","volume":"20","author":"Tyrer","year":"1990","journal-title":"Psychological Medicine"},{"key":"10.1002\/14651858.CD001130-BIB182|cit182","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1192\/bjp.162.2.219","article-title":"The Nottingham Study of Neurotic Disorder. Effect of personality status on response to drug treatment, cognitive therapy and self-help over two years","volume":"162","author":"Tyrer","year":"1993","journal-title":"British Journal of Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD001130-BIB183|cit183","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1600-0447.1992.tb08595.x","article-title":"The general neurotic syndrome: a coaxial diagnosis of anxiety, depression and personality disorder","volume":"85","author":"Tyrer","year":"1992","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"8605","key":"10.1002\/14651858.CD001130-BIB184|cit184","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0140-6736(88)92535-4","article-title":"The Nottingham Study of neurotic disorder: comparison of drug and psychological treatments","volume":"2","author":"Tyrer","year":"1988","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD001130-BIB185|cit185","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0022-3999(98)00072-5","article-title":"Long-term outcome of hypochondriacal personality disorder","volume":"46","author":"Tyrer","year":"1999","journal-title":"Journal of Psychosomatic Research"},{"issue":"1","key":"10.1002\/14651858.CD001130-BIB186|cit186","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1176\/ajp.140.1.11","article-title":"Dysthymic disorder: psychopathology of proposed chronic depressive subtypes","volume":"140","author":"Akiskal","year":"1983","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD001130-BIB187|cit187","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1177\/026988119400800407","article-title":"The efficacy of selective serotonin re-uptake inhibitors in depression: a meta-analysis of studies against tricyclic antidepressants","volume":"8","author":"Anderson","year":"1994","journal-title":"Journal of Psychopharmacology"},{"key":"10.1002\/14651858.CD001130-BIB188|cit188","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-II)","year":"1968"},{"key":"10.1002\/14651858.CD001130-BIB189|cit189","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-III)","year":"1980"},{"key":"10.1002\/14651858.CD001130-BIB190|cit190","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (3rd edn, revised) (DSM-III-R)","year":"1987"},{"issue":"8","key":"10.1002\/14651858.CD001130-BIB191|cit191","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.1996.03540080059030","article-title":"Improving the quality of reporting of randomized controlled trials","volume":"276","author":"Begg","year":"1996","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD001130-BIB192|cit192","unstructured":"Churchill R A systematic review and meta-analysis of the effects of pharmacotherapy and psychotherapy for the treatment of depression in primary care: A preliminary report MSc dissertation. London School of Hygiene and Tropical Medicine, 1996 1996"},{"issue":"1","key":"10.1002\/14651858.CD001130-BIB193|cit193","first-page":"3","article-title":"Standardized assessment of dysthymia: report of a National Institute of Mental Health conference","volume":"33","author":"Gwirtsman","year":"1997","journal-title":"Psychopharmacology Bulletin"},{"issue":"6984","key":"10.1002\/14651858.CD001130-BIB194|cit194","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/bmj.310.6984.897","article-title":"Efficacy of tricyclic drugs in treating child and adolescent depression: a meta-analysis","volume":"310","author":"Hazell","year":"1995","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD001130-BIB195|cit195","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1192\/bjp.170.2.120","article-title":"Discontinuation rates of SSRIs and tricyclic antidepressants: a meta-analysis and investigation of heterogeneity","volume":"170","author":"Hotopf","year":"1997","journal-title":"British Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD001130-BIB196|cit196","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1136\/jech.51.4.354","article-title":"Putting trials on trial - the costs and consequences of small trials in depression: a systematic review of methodology","volume":"51","author":"Hotopf","year":"1997","journal-title":"Journal of Epidemiology and Community Health"},{"issue":"2","key":"10.1002\/14651858.CD001130-BIB197|cit197","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00004714-199104000-00003","article-title":"Pharmacotherapy of dysthymia: a review","volume":"11","author":"Howland","year":"1991","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD001130-BIB198|cit198","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1001\/archpsyc.1994.03950010008002","article-title":"Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey","volume":"51","author":"Kessler","year":"1994","journal-title":"Archives of General Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD001130-BIB199|cit199","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000118485","article-title":"Fengabine, a new GABAmimetic agent in the treatment of depressive disorders: an overview of six double-blind studies versus tricyclics","volume":"20","author":"Magni","year":"1988","journal-title":"Neuropsychobiology"},{"key":"10.1002\/14651858.CD001130-BIB200|cit200","volume-title":"Cochrane Collaboration Handbook","author":"Mulrow","year":"1997"},{"key":"10.1002\/14651858.CD001130-BIB201|cit201","first-page":"77","article-title":"The mental health of populations","volume-title":"The Scope of Epidemiological Psychiatry","author":"Rose","year":"1989"},{"key":"10.1002\/14651858.CD001130-BIB202|cit202","volume-title":"Evidence-based medicine. How to practice and teach EBM","author":"Sackett","year":"1997"},{"issue":"6879","key":"10.1002\/14651858.CD001130-BIB203|cit203","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1136\/bmj.306.6879.683","article-title":"Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability","volume":"306","author":"Song","year":"1993","journal-title":"BMJ"},{"issue":"7","key":"10.1002\/14651858.CD001130-BIB204|cit204","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1176\/ajp.145.7.815","article-title":"The epidemiology of dysthymia in five communities: rates, risks, comorbidity and treatment","volume":"145","author":"Weissman","year":"1988","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD001130-BIB205|cit205","volume-title":"The ninth revision of the international classification of diseases and related health problems (ICD-9)","year":"1978"},{"key":"10.1002\/14651858.CD001130-BIB206|cit206","volume-title":"The tenth revision of the international classification of diseases and related health problems (ICD-10)","year":"1992"},{"key":"10.1002\/14651858.CD001130-BIB207|cit207","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1192\/bjp.166.2.174","article-title":"Dysthymia in clinical practice","volume":"166","year":"1995","journal-title":"British Journal of Psychiatry"}],"updated-by":[{"DOI":"10.1002\/14651858.cd001130.pub2","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2015,6,18]],"date-time":"2015-06-18T00:00:00Z","timestamp":1434585600000},"record-id":"32080"},{"DOI":"10.1002\/14651858.cd001130.pub2","type":"withdrawal","label":"Withdrawal","source":"publisher","updated":{"date-parts":[[2015,6,18]],"date-time":"2015-06-18T00:00:00Z","timestamp":1434585600000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD001130\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T07:24:17Z","timestamp":1734161057000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD001130"}},"subtitle":[],"editor":[{"given":"Mauricio","family":"Silva de Lima","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2005,4,20]]},"references-count":207,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd001130","relation":{},"subject":[],"published":{"date-parts":[[2005,4,20]]}}}